Inflammation and Sex Hormone Metabolism
- 30 June 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1069 (1) , 236-246
- https://doi.org/10.1196/annals.1351.021
Abstract
Abstract: The incidence of autoimmune diseases is higher in females than in males. In both sexes, adrenal hormones, that is, glucocorticoids, dehydroepiandrosterone (DHEA), and androgens, are inadequately low in patients when compared to healthy controls. Hormonally active androgens are anti‐inflammatory, whereas estrogens are pro‐inflammatory. Therefore, the mechanisms responsible for the alterations of steroid profiles in inflammation are of major interest. The local metabolism of androgens and estrogens may determine whether a given steroid profile found in a subject's blood results in suppression or promotion of inflammation. The steroid metabolism in mixed synovial cells, fibroblasts, macrophages, and monocytes was assessed. Major focus was on cells from patients with rheumatoid arthritis (RA), while cells from patients with osteoarthritis served as controls. Enzymes directly or indirectly involved in local sex steroid metabolism in RA are: DHEA‐sulfatase, 3β‐hydroxysteroid dehydrogenase, 17β‐hydroxysteroid dehydrogenase, and aromatase (CYP19), which are required for the synthesis of sex steroids from precursors, 5α‐reductase and 16α‐hydroxylase, which can be involved either in the generation of more active steroids or in the pathways leading to depletion of active hormones, and 3α‐reductase and 7α‐hydroxylase (CYP7B), which unidirectionally are involved in the depletion of active hormones. Androgens inhibit aromatization in synovial cells when their concentration is sufficiently high. As large amounts of estrogens are formed in synovial tissue, there may be a relative lack of androgens. Production of 5α‐reduced androgens should increase the local anti‐inflammatory activity; however, it also opens a pathway for the inactivation of androgens. The data discussed here suggest that therapy of RA patients may benefit from the use of nonaromatizable androgens and/or the use of aromatase inhibitors.Keywords
This publication has 23 references indexed in Scilit:
- Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: A prerequisite for local androgen deficiencyArthritis & Rheumatism, 2005
- CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: Regulation by proinflammatory cytokinesArthritis & Rheumatism, 2005
- Severity of murine collagen‐induced arthritis correlates with increased CYP7B activity: Enhancement of dehydroepiandrosterone metabolism by interleukin‐1βArthritis & Rheumatism, 2004
- Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2004
- Differential regulation of steroid 5α‐reductase isozymes expression by androgens in the adult rat brainThe FASEB Journal, 2003
- Distinguishing Androgen Receptor Agonists and Antagonists: Distinct Mechanisms of Activation by Medroxyprogesterone Acetate and DihydrotestosteroneMolecular Endocrinology, 1999
- Serum Dehydroepiandrosterone (DHEA) and DHEA Sulfate Are Negatively Correlated with Serum Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence and ImmunosenescenceJournal of Clinical Endocrinology & Metabolism, 1998
- Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1996
- Androgen replacement therapy in male patients with rheumatoid arthritisArthritis & Rheumatism, 1991
- Testosterone lowers aromatase activity in cultured human genital skin fibroblastsMolecular and Cellular Endocrinology, 1990